People

Alan Ashworth

Alan Ashworth

Alan Ashworth is a scientific adviser at Overwater Ventures. His cancer-research career includes discovering BRCA2 and work on synthetic lethality underlying PARP-inhibitor treatment approaches. Overwater’s biography describes UCSF cancer-center leadership and scientific co-founding of Tango Therapeutics; these outside affiliations remain source-qualified.

Roles

Current